Please login to the form below

Not currently logged in
Email:
Password:

Baring to raise USD 450m for third India fund

Baring Private Equity Partners says it will raise USD 450m for its third India fund for strategic investments in healthcare, pharmaceutical, IT-enabled services, FMCG and alternative energy generation sectors in India

Baring Private Equity Partners (BPEP) has said it will raise USD 450m for its third India fund for strategic investments in healthcare, pharmaceutical, IT-enabled services, FMCG and alternative energy generation sectors in India.

According to Akhil Awasthi, partner at BPEP India, approximately 30 per cent of the fund will be targeted toward the healthcare and pharmaceutical sectors in the region.

BPEP's investments in over 20 companies hail from its earlier India funds of an aggregate size of USD 200m. For example, BPEP raised USD 17m for the second India fund in 2004.

Awasthi said in a press conference: "Unlike several other sectors, healthcare and pharmaceutical is an ideal industry to leverage on intellectual capital. There are various niches, technologies and market segments that one could explore. There are at least 25-30 knowledge driven companies in this sector that could go for an expansion mode on their intellectual strengths."

BPEP has so far invested in three healthcare and pharmaceutical firms, including the pharmaceutical marketing analysis and consultant company, Pharmarc.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics